Ironsides Asset Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$464K Sell
3,923
-165
-4% -$19K 0.11% 59
2026
Q1
$489K Sell
4,088
-2,047
-33% -$268K 0.12% 57
2025
Q4
$835K Hold
6,135
0.21% 39
2025
Q3
$905K Buy
6,135
+140
+2% +$19.4K 0.23% 32
2025
Q2
$776K Buy
5,995
+120
+2% +$14.5K 0.22% 33
2025
Q1
$702K Buy
5,875
+2,580
+78% +$320K 0.21% 37
2024
Q4
$382K Sell
3,295
-205
-6% -$25.9K 0.11% 50
2024
Q3
$473K Buy
+3,500
New +$468K 0.14% 47

Other funds holding XYL

Ironsides Asset Advisors's XYL Position: Q2 2026 in Review

Ironsides Asset Advisors reduced its Xylem (XYL) stake by 4% in Q2 2026, selling an estimated $19K and leaving 3,923 shares worth $464K. The position accounts for 0.11% of the portfolio, ranked #59.

Ironsides Asset Advisors first reported a position in XYL in Q3 2024 and has held it in 8 quarters since. The position peaked at $905K in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Ironsides Asset Advisors held 3,923 shares of Xylem worth $464K as of Q2 2026.
  • Ironsides Asset Advisors sold 165 Xylem shares in Q2 2026, an estimated $19K.
  • Xylem made up 0.11% of Ironsides Asset Advisors's portfolio in Q2 2026, its #59 holding.
  • Ironsides Asset Advisors first reported a position in Xylem in Q3 2024 and has held it in 8 quarters since.
  • Ironsides Asset Advisors's Xylem position peaked at $905K in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Ironsides Asset Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.